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An Improved Model of House Dust Mite Allergic Sensitization 
Abstract 
The existing mouse models for allergic asthma are incapable of reproducing all of 
the immunogenic and physiological features of allergic asthma as seen in humans.  
Additionally, these models induce some changes inconsistent with human disease.  
Reasons for these inconsistencies could be the amount of allergen to which the mice are 
exposed, the way they are exposed, and inadvertent stress brought about through animal 
handling.  To address these issues, we attempted to create a novel mouse model of 
allergic asthma induction in which mice were persistently (for 6 weeks) exposed to zero, 
low (1µg/g), medium (10µg/g), and high (100µg/g) doses of house dust mite extract 
based on the Derp1 content/g inoculated into their bedding nestlets.  For this model, we 
based the amount of allergen inoculated into the bedding on epidemiological studies, 
which indicate that 5.5% of children living in homes containing a concentration of 10µg 
Derp1/g of carpet dust are allergically sensitized to house dust mite [1].  Therefore the 
doses of HDM delivered to the mice were more physiologically relevant and similar to 
what humans are exposed to.  The mice were not handled except for routine veterinary 
care and they were exposed to HDM through normal breathing instead of intranasal 
instillation.  At the end of the exposures, airway hyperresponsiveness was assessed and 
immunophenotyping was performed.  We found no significant differences in the 
methacholine hyperresponsiveness, the production of IgG1, IgE, and IgG2a, or the 
cytokine production between the treatment groups.  Since our model did not elicit 
methacholine hyperresponsiveness or HDM-specific immune responses, future studies 
will determine whether allergen sensitization elicited through a single intranasal 
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instillation of 1 µg HDM extract, followed by the 6-week persistent exposure to varying 
concentrations of HDM in the manner described above, elicits changes consistent with 
those found in human allergic asthmatics. 
 
Introduction 
Asthma is a common chronic disorder of the airways that involves a complex 
interaction of airway reactivity and inflammation [2].  About 300 million people suffer 
from asthma worldwide [3], and the US asthma prevalence is approximately 1 in 12 adults 
and 1 in 11 children [4]. The development of allergic asthma is linked to allergen 
sensitization, which is the act or process of inducing an acquired allergy.   
Asthma has been recognized as a set of symptoms related to difficulty in 
breathing since ancient times in China, Mesopotamia, and Greece [5].  Over the course of 
centuries the complexity of the disease has become more appreciated.  In an attempt to 
explain the mechanism behind asthma, the Th2-inflammation paradigm was described 
and explored by investigators in order to gain a better understanding of allergic asthma.  
In this process, exposure to an allergen in combination with genetic susceptibility leads to 
a heightened Th2-immune response that upregulates eosinophilic inflammation and tissue 
damage, causes airway hyperresponsiveness, and eventually leads to symptoms.  
However, this hypothesis is too simplistic and can’t account for variations in the clinical 
presentation of asthma or responses to treatment [6].   
Today there is an understanding that asthma is a very heterogenic disorder with 
affected individuals displaying a wide variety of clinical symptoms, pathologies, and 
responses to treatments [7].  The development and manifestation of asthma is the result of 
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complex interactions between genetic features that make individuals more susceptible to 
atopy and airway hyperresponsiveness, the environment, and the natural course of the 
disease. The clinical presentation of asthma can be separated out into different 
phenotypes and then further into endotypes, or subgroups, based on the pathophysiologic 
features, including clinical characteristics, biomarkers, lung physiology, genetics, 
histopathology, epidemiology, and response to treatment [7].  It is important to consider 
different endotypes of asthma because they can provide insight into the mechanisms 
behind different physiologies that cause the symptoms characteristic of asthma.   It is also 
important to create mouse models to align with the different endotypes seen in humans to 
gain a better understanding of the specific pathologies so that effective treatments can be 
designed.    
Using mouse models has been an important strategy for learning about the 
mechanisms and pathology associated with allergic asthma [7].  Traditional animal 
models utilized Alum/OVA with a standard time course for sensitization and challenge.  
In an attempt to better model human asthma, the traditional models have been 
supplemented with many physiologically relevant sensitizing agents, allergens and 
triggers; chronic time courses that better represent the natural history of asthma; and 
measures of lung remodeling that represent the diverse range of clinically observed 
indications of asthma [7].  The Th2 Hypothesis was one of the first targets of asthma 
research that utilized technology for genetically modified mice and molecular profiling 
methods.  The result is that the mechanisms of Th2 driven asthma are now understood 
down to the molecular level [8].  Understanding all of the potential mechanisms of 
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asthma in this level of detail is the goal of current research and this is why the creation of 
animal models that represent the different endotypes of asthma is vitally important. 
While progress has been made to better align animal models with human 
endotypes of asthma, existing mouse models are still insufficient.  The flaws of these 
models come from the allergic sensitization of the mice depending on irrelevant means, 
routes, doses, and duration of antigen exposure; the imposition of stress on the mice due 
excessive handling; and prohibitive costs due to the amount of time laboratory personnel 
must spend exposing the mice to antigens.  Additionally, the existing models lack the 
chronic inflammatory and epithelial changes of asthma seen in humans.  They can also 
result in pulmonary parenchymal inflammation, alveolitis, and pneumonitis [9] along 
with vascular remodeling and fibrotic changes that are inconsistent with human asthma 
[10].  Another problem is that most models of acute allergen exposure result in airway 
pathologies that peak 24-72 hours after the allergen challenge and resolve in 1-2 weeks, 
making it difficult to study the effects of drugs designed to control the chronic pathologic 
processes of asthma [11].  As a result of these imperfect models, it has been very difficult 
to develop therapeutic treatments for humans because treatments that appear to work in 
mouse models more often than not fail in human trials due to the differences in 
physiology [12]. 
House dust mite (HDM) is a ubiquitous perennial allergen source and a major 
cause of allergic asthma worldwide.  It is estimated that as much as 1-2% of the general 
population is sensitized to HDM and as many as 50% of asthmatic patients are reactive to 
HDM [13].  The major antigens found in the two most prevalent species of HDM are 
Derp1 and Derf1 (from Dermatophagoides pteronyssinus and D. farinae).  
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Epidemiological studies in humans have linked the prevalence of these two proteins in 
household dust to the likelihood of developing allergic sensitization.  When homes 
contained a concentration of 10µg Derp1 and Derf1/g of carpet dust, a peak level 5.5% of 
children from 0-3 years old were found to be allergically sensitized to house dust mite.  
Concentrations below 0.1g Derp1 and Derf1/g of carpet dust were associated with a low 
risk of allergic sensitization [1].  Other studies have predicted the greatest risk of HDM 
sensitization to occur when people are exposed to 3.5-23.4µg Derp1/g of bed or airborne 
dust, with levels lower than 2µg/g considered safe [13, 14]. 
We attempted to create an improved model for allergically sensitizing mice to 
house dust mite that promotes an asthmatic physiologic and immunologic phenotype and 
also better reflects the natural route, dosing, and duration of allergen exposure 
experienced by humans.  Based on the epidemiological studies, we inoculated low, 
optimal, and high doses of house dust mite, based on Derp1 content, into the nestlets that 
mice shred to prepare their bedding nests so that the allergen exposure would be 
persistent and through a route of exposure similar to that of humans.  The mice were 
handled only during cage changes and for routine veterinary care.  Consequently, the 
personnel time required for the work was substantially reduced compared to other 
models. The success of this model was evaluated by measuring the major parameters 
associated with allergic asthma, including methacholine responsiveness, airway 
inflammation, lung histology, and the adaptive immune response, as well as measures of 
systemic distress.  Results from this model were compared to the Poynter laboratory’s 
existing data from a frequently used model of intranasal house dust mite extract exposure.   
 
Susan	  Kostin	  	   	   6	   	  
Materials and Methods 
Mice 
3 week old female BALB/cJ and C57BL/6J mice were purchased from Jackson 
Laboratories (Bar Harbor, ME) and acclimated for one week prior to initiating allergen 
exposure.  Mice were housed in an American Association for the Accreditation of 
Laboratory Animal Care (AALAC)-approved facility, maintained on a 12h light/dark 
cycle, and provided food and water ad libitum.  The University of Vermont Institutional 
Animal Care and Use Committee approved these studies. 
BALB/cJ mice were used for these experiments because they are particularly 
sensitive to developing airway hyperresponsiveness in response to methacholine [15].  
C57BL/6J mice were used for these experiments because they are the preferred strain for 
making genetic models.   
Develop an optimized model of house dust mite exposure 
Freeze-dried and pulverized extracts of whole D. pteronyssinus (Greer, Lenoir, 
NC which provides lot-specific information on total protein, endotoxin, and Derp1 
content) were resuspended in sterile water at a concentration of 1mg Derp1/1mL of H2O.  
The resuspended HDM extract was combined with sterile water to create low (1µg/g), 
optimal (10µg/g), and high (100µg/g) doses based on the Derp1 content/g of nestlet.  The 
varying doses of HDM were then inoculated onto the nestlets that mice shred to prepare 
their bedding nests, which were subsequently air-dried.  Nestlets were also inoculated 
with only water to serve as a control and then air-dried.  Nestlets were added to the cages 
of 4-week-old mice (female, C57BL/6J and BALB/cJ) for 6 weeks and replaced twice 
each week throughout the exposure period.  Half way through the exposure, used nestlet 
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material was collected, weighed, and frozen until subsequent aqueous extraction and 
quantitation of Derp1. 
Aqueous extraction of HDM from bedding and Derp1 ELISA 
 Used and unused bedding was soaked in 10mL of sterile water per gram of 
bedding for 30 minutes as previously described [16].  Subsequently, the water was 
pushed out of the bedding using a syringe.  The Derp1 content of the bedding was 
assessed by ELISA (Indoor Biotechnologies, Charlottesville, VA).  The wells of a high-
binding 96-well microtiter plate (Corning, Kennebunk, ME) were coated with mAb at 
10µL/10mL in 50mM carbonate-bicarbonate buffer, pH 9.6, and incubated overnight at 
4°C.  The plate was washed three times with PBS-0.05% Tween 20 (PBS-T) and then 
blocked for 30 minutes with 1% BSA, PBS-T.  After this, the plate was washed three 
times and the standards and samples were added for 1 hour.  The plate was then washed 
three times with PBS-T and the detection antibody was added to the plate for 1 hour.  The 
plate was again washed three times with PBS-T and streptavidin-HRP was added for 30 
minutes.  The plate was then washed 4 times and chromogenic substrates A and B (R&D 
Systems, Minneapolis, MN) were added in a 1:1 ratio.  Once the plate was developed, the 
reaction was stopped with 2N H2SO4.  The plate was read on a BioTek PowerwaveX 
(Winooski, VT) instrument at 450nm with a λ correction of 570nm using the program 
Gen5 1.1.  The absorbance of the samples were compared to the absorbance of the 
standards of known concentrations to calculate the concentrations of Derp1 present in the 
bedding.      
Perform in vivo assessment of methacholine responsiveness 
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 Mice were anesthetized by intra-peritoneal injection of sodium pentobarbital (90 
mg/kg), and the trachea was dissected free of surrounding tissue and cannulated with a 
blunted 18-gauge needle.  The mice were then connected to a SciReq flexiVent small 
animal ventilator for analysis, as has been previously described [17].  Airway resistance 
(RN), tissue damping (G), and tissue resistance (H) were calculated at baseline and after 
challenge with three incremental doses of aerosolized methacholine (12.5, 25, and 50 
mg/ml) in saline.  The peak average was calculated by taking the average of maximum 
values from each animal at each dose with the values directly preceding and following. 
Assess lung inflammation 
Following methacholine responsiveness measurements, mice were removed from 
the ventilator, lungs were lavaged with 1 mL of DPBS (Sigma-Aldrich, St. Louis, MO), 
the BAL fluid was centrifuged, and all cells in the pellet were resuspended in saline and 
enumerated by counting with an Advia 120 Hematology System.  Differential analysis 
was performed by cytospin and H&E stain from approximately 200 cells per slide.  
Serum Immunoglobulin ELISAs to measure house dust mite-specific immune responses  
Blood was collected by cardiac puncture, serum was prepared, and it was stored 
for subsequent analysis of House Dust Mite-specific IgE, IgG1, and IgG2a (BALB/c) or 
IgG2c (C57BL/6) by ELISA.  These ELISA assays were performed using 1:4 serial 
dilutions over the range of 1:10-1:163,840 for the positive control samples and over the 
range of 1:640 for the serum samples.  The serum samples from the IgG1 plate were 
transferred to the coated and blocked IgE plates after they had been on the IgG1 plates for 
2 hours.  The experimental serum samples were compared to a positive control sample of 
mice that had been sensitized and challenged intranasally with HDM.    
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The wells of high-binding 96-well microtiter plates were coated with 1 µg/ml 
HDM extract (Greer, Lenoir, NC) in PBS overnight.  The next day, the plates were 
blocked with 1% BSA for 1 hour, washed three times with PBS-T, and loaded with serum 
diluted 1:10 for 2 hours.  After this, the plates were washed 3 times and 2 µg/ml of 
biotinylated anti-mouse isotype-specific antibodies (BD Biosciences, San Jose, CA) were 
added for 1 hour.  The plates were again washed three times and streptavidin-HRP was 
added for 30 minutes.  The plates were then washed 4 times and chromogenic substrates 
A and B (R&D Systems, Minneapolis, MN) were added in a 1:1 ratio.  Once the plate 
was developed, the reaction was stopped with 2N H2SO4.  The plates were read on a 
BioTek PowerwaveX (Winooski, VT) instrument at 450nm with a correction of 570nm 
using the program Gen5 1.1.   
In vitro antigen restimulation and cytokine quantitation 
Following mechanical disruption of the spleen through a 70 µm mesh filter, 
splenocytes were isolated using Lymphocyte Separation Media (MP Biomedicals, Solon, 
OH), as previously described [18].  Cells were counted with an Advia 120 Hematology 
System and 4x106 cells/ml were cultured in RPMI-1640 supplemented with 5% FBS 
(Cell Generation, Fort Collins, CO), 1 mM sodium pyruvate, 2500 µg/ml glucose, 
100U/ml penicillin, 100 µg/ml streptomycin, 2 mM L-glutamine, 10 µg/ml folic acid, and 
50 µM 2-mercaptoethanol and treated with 15 µg/ml HDM extract (Greer).  Supernatants 
were collected after 96 hours of incubation at 37°C in 5% CO2.  Analysis of cytokine 
content from cell supernatants was performed using a custom Magnetic Luminex Screen 
Assay kit for IL-5, IL-13, IL-4, IL-10, IL-17A, and IFNγ (R&D Systems, Minneapolis, 
MN). 
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Magnetic Luminex Screening Assay 
 All reagents, standards, and samples were prepared according to the 
manufacturer’s instructions.  The resuspended, diluted microparticle cocktail was added 
to the 96 well microplate.  The standards and sample were then added to the plate and 
incubated at room temperature for 2 hours.  The plate was then washed three times and 
diluted biotin antibody cocktail was added for 1 hour.  Following this, the plate was 
washed three times, Streptavidin-PE was added for 30 minutes, and then washed again 
three times.  Finally, the microparticles were resuspended in wash buffer and the plate 
was read using a Bio-Plex Multiplex System (Bio-Rad, Hercules, CA).  
Quantitate stress and distress elicited from allergen exposure 
The stress hormone cortisol was measured using competitive ELISA (R&D 
Systems, Minneapolis, MN) according to the manufacturer’s protocol.  Serum was 
diluted 1:400.  Calibrator diluent, standards, diluted serum samples, cortisol conjugate, 
and primary antibody were added to the plate and incubated for 2 hours at room 
temperature. The plate was then washed three times, substrate solution was added for 30 
minutes, and then the reaction was stopped.   The plates were read on a BioTek 
PowerwaveX (Winooski, VT) instrument at 450nm with a correction of 570nm using the 
program Gen5 1.1.  The absorbance of the samples were compared to the absorbance of 
the standards of known concentrations to calculate the concentrations of cortisol.  
Statistical Analysis 
 Results were analyzed by one-way ANOVA with Tukey’s post hoc test and by 
two-tailed unpaired parametric t test with Welch’s correction using GraphPad Prism 6 for 
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Macintosh (GraphPad, La	  Jolla,	  CA).  *p=<0.05, **p=<0.01, ***p=<0.001, 
****p=<0.0001 compared to the 0 HDM dose unless otherwise noted by bracket.     
Results 
Derp1 was inoculated into nestlets in the desired physiologically relevant doses and did 
not degrade significantly with use.   
To ensure that the 
house dust mite extract was 
successfully inoculated into the 
nestlets in the desired 
physiological relevant doses 
and that it did not degrade 
significantly over time with use 
and freezing, an ELISA assay 
was performed to measure the 
Derp1 content.  Nestlets used by 
BALB/cJ mice and C57BL/6J 
mice along with unused nestlets of each HDM dose were soaked in sterile dH2O for 30 
minutes to resuspend the HDM extract.  The liquid was then squeezed from the bedding 
material and used for analysis.  There was a significant and dose-dependent difference in 
the Derp1 content present in the unused nestlets and the nestlets used by the BABL/cJ 
and C57BL/6J mice based on the dose of HDM with which the nestlets had been 
inoculated (Figure 1).  The measured content of Derp1 also matched the physiologically 
relevant doses that we were attempting to inoculate into the nestlets.  Therefore, it was 
 0  1 10 10
0  0 1 10 10




















Figure 1:  Derp1 ELISA to assess HDM content in nestlets.  
HDM was extracted from frozen unused nestlets and samples 
of nestlets used by BALB/cJ and C57BL/6J mice by 
resuspending in 10mL of sterile water per 1g of bedding 
material.  Triplicate samples of bedding were used. 
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determined that the method for inoculating nestlets with varying doses of HDM was 
successful. 
 
Mice sensitized with varying doses of HDM inoculated into their bedding did not display 
airway hyperresponsiveness. 
 Measuring the response to inhaled methacholine is a well-characterized method 
for assessing airway hyperresponsiveness (AHR), one of the characteristic symptoms of 
allergic asthma [19].  To assess this important variable, mice sensitized with the varying 
doses of HDM based on Derp1 content underwent methacholine challenge and were 
measured using forced oscillations.  There were no differences in the levels of Newtonian 
airway resistance (RN), tissue damping (G), or tissue stiffness (H) between any of the 
groups in either BALB/cJ or C57BL/6J mice.  Additionally, the slope of the 
methacholine dose dependent curves did not increase dramatically (Figures 2 & 3).  This 
indicates that none of the doses of HDM inoculated into the bedding nestlets for 
sensitization promoted the development of airway hyperresponsiveness.    
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Figure 2:  Assessment of airway hyperresponsiveness to inhaled methacholine in BALB/cJ mice.  
The mice were exposed to 0, 1, 10, or 100 µg/g doses of HDM based on the Derp1 content.  Forced 
oscillations by the flexiVent were used to assess measures of RN, G, and H as well as the responsiveness 
to inhaled methacholine. n = 10 mice per/group. 
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There were no differences in the house dust mite specific immune responses of the mice 
based on what dose of HDM they were sensitized with.   
  Blood from BALB/cJ and C57BL/6J mice exposed to the different doses of 
HDM was collected upon death and serum was prepared.  Serum immunoglobulin 
ELISAs were performed to measure the concentration of IgG1, IgG2a/IgG2c, and IgE.  
These immunoglobulins were also measured in serum samples from a mouse that was 
sensitized to HDM intranasally.  There were no significant differences in the 
concentrations of the different immunoglobulins in either strain of mice based on the 
dose of HDM that they were exposed to.  There was no statistically significant difference 
Figure 3: Assessment of airway hyperresponsiveness to inhaled methacholine in C57BL/6 mice.  
The mice were exposed to 0, 1, 10, or 100 µg/g doses of HDM based on the Derp1 content.  Forced 
oscillations by the flexiVent were used to assess measures of RN, G, and H as well as the responsiveness 
to inhaled methacholine. n = 10 mice per/group. 
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in the concentrations of each type of immunoglobulin between the positive control and 
the serum samples (Figures 4 & 5).  
 



















Figure 4:  Immunoglobulin ELISAs on serum from BALB/cJ mice.  The mice 
were exposed to varying concentrations of HDM inoculated into their bedding 
and compared to a positive control serum sample from mice sensitized to HDM 
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T cell stimulation was not influenced by the dose of Derp1 and antigen stimulation does 
not promote cytokine production. 
 Splenocytes were isolated from BALB/cJ and C57BL/6J mice exposed to varying 
amounts of HDM in their bedding.  The splenocytes were cultured in the absence or 
presence 15 µg/ml HDM extract for 96 hours.  The concentrations of the cytokines IL-10 
and IL-17A were undetectable in both strains of mice.  While there were some dose 
dependent differences in the production of IL-13 and IFNγ in both strains there was no 
consistent trend indicating that the varying doses of HDM promoted T cell stimulation.  
The only observed difference in cytokine production between the stimulated and 
unstimulated T cells was in the production of IL-4 for one HDM dose in each strain 
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Figure 5: Immunoglobulin ELISAs on serum from C57BL/6J mice.  The mice 
were exposed to varying concentrations of HDM inoculated into their bedding and 
compared to a positive control serum sample from mice sensitized to HDM 
intranasally to study the immune response to HDM.  n = 10 mice per/group. 
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(Figures 6 & 7).  Since the difference between stimulated and unstimulated cells was not 
more wide spread, this indicates that antigen stimulation does not promote cytokine 




Figure 6:  Cytokine panel of re-stimulated and unstimulated splenocytes from BALB/cJ mice to 
asses inflammation.  The mice were exposed to 0, 1, 10, or 100 µg/g doses of HDM based on the 
Derp1 content.  Positively selected splenic CD4+ T cells from BALB/cJ mice were cultured in the 
presence of antigen-presenting cells isolated from naive BALB/cJ mice and 1 µg of HDM extract for 96 
hours.  Cytokine concentrations were measured by Luminex. n= 10 mice/group. 










































































































Cortisol production was not influenced by the dose of Derp1 that mice are exposed to. 
 Cortisol is a 
hormone that is 
associated with the 
natural stress response 
[20].  Serum from 
BALB/cJ and C57BL/6J 
mice that were exposed to 
different doses of HDM was 
Figure 7:  Cytokine panel of re-stimulated and unstimulated splenocytes from C57BL/6J mice to 
asses inflammation.  The mice were exposed to 0, 1, 10, or 100 µg/g doses of HDM based on the 
Derp1 content.  Positively selected splenic CD4+ T cells from C57BL/6J mice were cultured in the 
presence of antigen-presenting cells isolated from naïve C57BL/6J mice and 1 µg of HDM extract for 
96 hours.	  Cytokine concentrations were measured by Luminex. n= 10 mice/group. 


































Figure 8: Cortisol ELISAs to assess stress.  Cortisol ELISAs were 
performed on the serum of BALB/cJ and C57BL/6J mice treated with 
0, 1, 10, or 100 µg/g doses of HDM based on the Derp1 content.  n = 
10 mice per/group.  
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analyzed by cortisol ELISA.  While there was one statistically relevant difference in the 
cortisol levels between the different doses of HDM, the overall values in both strains 
were very similar (Figure 8).  Therefore, mice exposed to varying doses of HDM do not 
have different stress levels.   
 
The concentrations of leukocytes in the lavageable airspaces were not dependent on the 
dose of Derp1 to which mice were exposed. 
 BAL cells were isolated from the BAL fluid collected during the harvest of 
BALB/cJ and C57BL/6J mice that were exposed to different concentrations of HDM 
based on Derp1 content.  While there was one difference in the concentration of 
macrophages in the BAL between doses in both strains, the differences were between two 
different doses (Figure 9).  Therefore, there is no indication that the concentration of 
house dust mite based on Derp1 content inoculated into bedding nestlets causes 
differential production of immune cells.  
 
 




 There is an existing need for animal models that more accurately display the 
pathophysiological features of the different endotypes of asthma and chronic nature of the 
disease [7].  To address the issues of the existing animal models, we attempted to create a 
model that utilized physiologically relevant doses of allergen, a natural route of exposure, 
a more relevant duration of allergen exposure, and involved minimal handling of the 
mice.  The doses of HDM inoculated into the bedding nestlets were based on 
epidemiological studies that indicated that children exposed to Derp1 (a component of 
HDM) levels of 10µg/g of bedding had an increased risk for becoming allergically 
sensitized to HDM [1].   



























































































































































































Figure 9:  Differential cell counts of cytospins of BAL cells from BALB/cJ and C57BL/6J mice.  
The mice were exposed to 0, 1, 10, or 100 µg/g doses of HDM based on the Derp1 content.  Upon 
harvest lungs were lavaged with 1 mL of DPBS, BAL fluid was collected BAL fluid was centrifuged, 
and all cells in the pellet were resuspended in saline.  Differential analysis was performed by cytospin 
and H&E stain from approximately 200 cells per slide.  n = 10 mice per/group.  
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The physiologically relevant doses of 0, 1, 10, & 100µg Dep1/g of bedding were 
successfully inoculated into the nestlets (Figure 1).  Additionally these doses of HDM 
remained stable over time with use and being stored in the freezer.  It would be expected 
for the samples from the used nestlets to have lower detectable amounts of Derp1 
compared to the unused nestlet samples because some HDM would be spread throughout 
the cage environment.  This pattern was seen for the 1 and 10 doses of Derp1, but the 
Derp1 concentrations in the 100 dose were very similar for both used and the unused 
samples.  It is possible that HDM accumulated in the cage environment in between cage 
changes as fresh nestlets were added twice weekly and HDM would be spread around the 
cage upon the shredding of the nestlets.  Therefore HDM from previous nestlets could 
end up in the bedding material. 
Measuring the response to inhaled methacholine is a well-characterized method 
for assessing airway hyperresponsiveness, one of the hallmarks of allergic asthma that is 
present in most patients [19].  The presence of AHR in humans and animal models has 
been associated with chronic changes in the structure of airways, including subepithelial 
thickening, subbasement membrane thickening, smooth muscle hypertrophy, matrix 
deposition, and altered vascular components [21].  Additionally, the acute effects of 
inflammation caused by environmental factors can influence AHR and may explain why 
there is such a variety in the degree of AHR seen in asthmatic patients [21]. In our model, 
there was no airway hyperresponsiveness in response to inhaled methacholine and no 
significant differences in airway hyperresponsiveness depending on what dose of Derp1 
the mice were exposed to.  This indicates that there were no chronic structural airway 
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changes or environmental factors causing acute inflammation that would have caused 
AHR. 
The serum immunoglobulin isotypes IgG1 and IgG2a/IgG2c are markers of Th1 
and Th2 lymphocytes, respectively [22].  The immunoglobulin IgE is the isotype that is 
primarily associated with allergic (Th2) inflammation [23].  The Th1 response activates 
macrophages in response to a pathogen, leading to inflammation aimed at eliminating 
intracellular pathogens.  In asthmatics there is an imbalance between the Th1 and Th2 
responses, leaning more heavily towards the Th2 response [24].  The high level of 
activation of the Th2 response causes the increased expression of cytokines that lead to 
the activation of eosinophils and the subsequent production of the IgE that is responsible 
for producing the allergy associated inflammation, which under normal situations is adept 
at eliminating extracellular parasites [25].  Since our model indicated that there were no 
differences in the production of these immunoglobulins for different doses of Derp1, the 
dose of HDM inoculated into the bedding nestlets did not heighten either the Th1 or Th2 
immune responses (Figures 4 & 5).     
 The Th2 and Th17 immune responses are strongly associated with allergic asthma 
and a mixed Th2/Th17 response is reminiscent of severe asthma phenotypes [26].   The 
Th2 response develops in response to environmental allergens. CD4+ T cells are 
activated to produce the cytokines IL-4, IL-5, and IL-13, which are responsible for 
promoting the production of IgE by B cells, eosinophil activation and recruitment, and 
mucus production [24].  The Th1 response occurs in response to microbial infections and 
activates macrophages and helps B cells with antibody production (particularly IgG2).  
The cytokines IFN-γ and IL-4 counter-regulate each other [27].  Therefore, the stronger 
Susan	  Kostin	  	   	   23	   	  
response should have higher levels of its characteristic cytokines.  The effector cytokines 
of the Th17 response, including IL-17, indirectly promote the recruitment of neutrophils 
and cause acute inflammation [26].  IL-10 is an anti-inflammatory cytokine that inhibits 
the Th1 response [28].  Our data showed that there was no differential activation of the 
Th1, Th2, and Th17 responses based on the dose of Derp1 to which mice were exposed 
(Figures 6 & 7).  For IL-10 and IL-17A, all of the values were out of range for detection.  
Most of the values for all of the other cytokines were beyond the lower level of 
quantitation and were extrapolated from the standard curve.  There was also no 
widespread difference in cytokine production between the stimulated and unstimulated 
splenocytes.  The purpose of testing this difference was to see whether or not a memory 
response was elicited.  If the mice had been successfully sensitized the administration of 
HDM in vitro should have caused more cytokine production.  Taken together with the 
results of the serum immunoglobulin ELISAs this indicates that a house dust mite 
specific immune response did not develop in this model.   
Corticosterone is the main steroid hormone involved in the stress response in 
rodents.  Both corticosterone and cortisol are present in serum, have similar dynamics 
under normal non-stressful conditions, and increase during stressful events.  
Corticosterone is a more adaptation-related biomarker and decreases during chronic stress 
whereas cortisol responds faster to severe acute stress [20].  A previous study 
demonstrated that under normal conditions the concentration of cortisol in the serum was 
under 15ng/mL and peaked around 45ng/mL in response to a chronic stressor [20].  In 
contrast, the cortisol levels measured in our model were between 2,000 and 4,000 ng/mL.  
Since these cortisol levels were so high, any observed differences between treatment 
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groups are irrelevant.  This may indicate that our mice were eliciting extremely large 
stress responses.  However, the indicated high levels of stress could instead be unrelated 
to the stress they experienced as a consequence of their living conditions.  Instead, the 
manner in which the mice were killed, and what they experienced in the flexiVent 
analysis preceding their euthanasia, could have elevated their cortisol levels.  In many 
studies that examine cortisol levels, euthanasia is performed by decapitation [20, 29].  In 
contrast, our mice were woken up in the middle of their sleep cycle, anesthetized, 
subjected to forced oscillations of methacholine, and then harvested.  In a study on 
golden hamsters, cortisol levels were positively correlated with the amount of time that it 
took to capture the hamsters before the administration of anesthesia and decapitation 
[30].  Since our mice were handled much more, subjected to flexivent, and the method of 
euthanasia is slower than instant death by decapitation, all of these could have 
contributed to the increased cortisol levels.  Additionally, the anesthetic that was used 
may have influenced the cortisol levels.  The cortisol levels from this model were 
compared to those from a traditional intranasal model and they were not statistically 
different.  However, cortisol levels rise in response to acute severe stressors and since the 
animals are harvested in the same manner in both models, this could account for the 
similarity in the measured cortisol levels.  In order to test whether the attempted model 
causes less stress on the animals, they would need to be anesthetized and immediately 
decapitated for the purpose of measuring cortisol rather than going through the flexivent 
process and subsequent harvest of organs. 
Leukocytes, commonly referred to as “immune cells” play an important role in 
the pathology of different asthma endotypes.  Increased levels of eosinophils are 
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characteristic in Th2 driven [25] disease and increased levels of neutrophils are more 
characteristic of Th17 driven disease [26].  T cells are a type of lymphocyte that plays a 
major role in the development and pathophysiology of allergic asthma.  In particular the 
CD4+ Th2 lymphocytes help to induce some of the inflammation by promoting the 
activation and recruitment of eosinophils [24, 31].  Macrophages are primarily associated 
with the innate immune response and are responsible for the phagocytosis of foreign 
materials and inducing inflammation.  Th2 cytokines, which are overexpressed in Th2 
driven asthmatics, promote macrophages to induce inflammation.  The inflammatory 
factors produced by macrophages are meant to maintain pulmonary homeostasis; 
however, when they are overexpressed they cause tissue damage [32].  In our model, 
there were no differences in the amount of total cells, macrophages, neutrophils, 
eosinophils, or lymphocytes that were present in the bronchoalveolar lavage (BAL) fluid 
of mice exposed to the four different doses of house dust mite.  This indicates that the 
HDM inoculated into the bedding nestlets did not influence the production and 
recruitment of immune cells.    
In these studies, we determined that the approach for this model was not 
successful in inducing an asthmatic physiologic and immunologic phenotype.  In 
traditional models of sensitization and challenge to house dust mite used by our lab mice 
develop airway hyperresponsiveness in response to methacholine, have elevated levels of 
eosinophils and lymphocytes in the BAL fluid, produce HDM immunoglobulins, produce 
cytokines associated with the Th2 response, and display immunologic memory.  Since 
there was no display of airway hyperresponsiveness or house dust mite specific immune 
responses, future studies will determine whether allergen sensitization and asthma-like 
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changes in the lung can be elicited through a single intranasal instillation of 1 µg HDM 
extract, followed by the protracted 6-week challenge of persistent exposure to varying 
concentrations of HDM inoculated into the bedding nestlets of mice.  It will also be 
determined whether or not the changes that occur are consistent with those found in 
human allergic asthmatics.  Previous studies have found that a single intranasal 
instillation of 1 µg HDM extract and subsequent challenge with 10 µg HDM one week 
later on five consecutive days has been successful in inducing allergic sensitization and 
asthma-like changes in the lung [33].  Once the model has been optimized, it will be used 
test for the exacerbation of disease in response to challenge with relevant triggers: a 
higher dose of allergen exposure, influenza virus infection, nitrogen dioxide, and 
simultaneous subjection to a high fat diet.  If successful, this model could be useful for 
creating new treatments for asthma due to the natural route for allergen delivery, the 
persistent exposure, and physiologically relevant doses of HDM based on Derp1 content 
which more accurately reflect how humans develop asthma. 
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